Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceutical Drugs MGR 2017

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 22020

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 22020

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 33030

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
AED 22020

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 44040

Details

The market segments in the pharmaceuticals drugs sector as of 2016 were Oncology, Anti-diabetics, Anti-rheumatics, Anti-virals, Vaccines, Bronchodilators, Sensory Organs, Anti-hypertensives, MS Therapies, Immunosuppressants, Anti-coagulants, Dermatologicals, Anti-hyperlipidaemics, Anti-fibrinolytics and Anti-bacterials.

Pharmaceuticals Drugs was the largest segment in the pharmaceuticals market with over 80% share of the market. Pharmaceuticals Drugs are chemical substances used to treat, cure, prevent or diagnose a disease. Biologics was the second largest segment in the pharmaceuticals market with around 20% share of the market. Biologics comprises products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins extracted or semi synthesized from biological sources.

The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.

Rise of Biologics/Gene Therapy was observed to be one of the top trends in the pharmaceuticals industry as of 2016. Advances in genetics, molecular biology and gene delivery technologies have led to an increase in gene therapies to treat a number of diseases. Gene therapy treatment includes the isolation and transfer of stem cell populations, administration of effector cells and induction of pluripotent cells. Applications of gene therapy and biologics are primarily in cancer, cardiovascular and central nervous system diseases. Gene therapy is being widely used by healthcare service providers as it has the potential to cure hereditary diseases such as cystic fibrosis and also has the scope to treat heart diseases and cancer. For instance, cancer gene therapy is expected to be around $4.3 billion, thus indicating high demand for gene therapy

The Pharmaceutical Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases

Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Table Of Content

Scope

1. Pharmaceutical Drugs Market Characteristics;

2. Pharmaceutical Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Pharmaceutical Drugs Market Customer Information;

5. Pharmaceutical Drugs Market Segmentation;

5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;

6. Pharmaceutical Drugs Market Regional And Country Analysis;

6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;

7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;

7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;

8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;

9. Pharmaceutical Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Pharmaceutical Drugs Market;

10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

11. Western Europe Pharmaceutical Drugs Market;

11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

12. Eastern Europe Pharmaceutical Drugs Market;

12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

13. North America Pharmaceutical Drugs Market;

13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

14. South America Pharmaceutical Drugs Market;

14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

15. Middle East Pharmaceutical Drugs Market;

15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;

16. Africa Pharmaceutical Drugs Market;

16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;

17. Pharmaceutical Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

19. Market Background: Pharmaceuticals Market;

19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;

20. Healthcare Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Pharmaceutical Drugs Historic Market Growth

Table 2: Global Pharmaceutical Drugs Forecast Market Growth

Table 3: Pharmaceutical Drugs Market Segmentation

Table 4: Global Pharmaceutical Drugs Market, 2016, By Segment

Table 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016

Table 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Table 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region

Table 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country

Table 10: Global Cardiovascular Disorders Market, 2016, By Segment

Table 11: Global Dermatology Market, 2016, By Segment

Table 12: Global Gastrointestinal Diseases Market, 2016, By Segment

Table 13: Global Genito-urinary Disorders Market, 2016, By Segment

Table 14: Global Hematology Market, 2016, By Segment

Table 15: Global Infectious Diseases Market, 2016, By Segment

Table 16: Global Metabolic Disorders Market, 2016, By Segment

Table 17: Global Musculoskeletal Disorders Market, 2016, By Segment

Table 18: Global Central Nervous System Market, 2016, By Segment

Table 19: Global Oncology Market, 2016, By Segment

Table 20: Global Ophthalmology Market, 2016, By Segment

Table 21: Global Respiratory Diseases Market, 2016, By Segment

Table 22: Global Pharmaceutical Drugs Market, 2016, By Region

Table 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 24: Pharmaceutical Drugs Market, 2016, By Country

Table 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 26: Global Healthcare Market Segments, 2016, By Region;

Table 27: Global Pharmaceutical Market Segments, 2016, By Region;

Table 28: Global Healthcare Market Segments, 2016, By Country;

Table 29: Global Pharmaceutical Market Segments, 2016, By Country;

Table 30: Global Pharmaceuticals Market Segments, 2016, By Region

Table 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 32: Global Pharmaceuticals Market Segments, 2016, By Country

Table 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 39: Global Number Of Pharmacists, 2016, By Country

Table 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 41: Global Number Of Pharma Enterprises, 2016, By Country

Table 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 43: Global Average Spending On R&D/Product Development, 2016, By Country

Table 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 47: Global Number Of General Practitioners 2016, By Country

Table 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016

Table 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020

Table 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment

Table 52: China Pharmaceutical Drugs Historic Market, 2012-2016

Table 53: China Pharmaceutical Drugs Forecast Market, 2016-2020

Table 54: China Pharmaceutical Drugs Market, 2016, By Segment

Table 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 57: India Pharmaceutical Drugs Historic Market, 2012-2016

Table 58: India Pharmaceutical Drugs Forecast Market, 2016-2020

Table 59: India Pharmaceutical Drugs Market, 2016, By Segment

Table 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016

Table 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020

Table 64: Japan Pharmaceutical Drugs Market, 2016, By Segment

Table 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016

Table 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020

Table 69: Australia Pharmaceutical Drugs Market, 2016, By Segment

Table 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016

Table 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Table 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment

Table 75: UK Pharmaceutical Drugs Historic Market, 2012-2016

Table 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020

Table 77: UK Pharmaceutical Drugs Market, 2016, By Segment

Table 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016

Table 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020

Table 82: Germany Pharmaceutical Drugs Market, 2016, By Segment

Table 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 85: France Pharmaceutical Drugs Historic Market, 2012-2016

Table 86: France Pharmaceutical Drugs Forecast Market, 2016-2020

Table 87: France Pharmaceutical Drugs Market, 2016, By Segment

Table 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016

Table 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020

Table 92: Italy Pharmaceutical Drugs Market, 2016, By Segment

Table 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016

Table 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020

Table 97: Spain Pharmaceutical Drugs Market, 2016, By Segment

Table 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016

Table 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Table 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment

Table 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016

Table 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020

Table 105: Russia Pharmaceutical Drugs Market, 2016, By Segment

Table 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 108: North America Pharmaceutical Drugs Historic Market, 2012-2016

Table 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020

Table 110: North America Pharmaceutical Drugs Market, 2016, By Segment

Table 111: USA Pharmaceutical Drugs Historic Market, 2012-2016

Table 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020

Table 113: USA Pharmaceutical Drugs Market, 2016, By Segment

Table 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 116: South America Pharmaceutical Drugs Historic Market, 2012-2016

Table 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020

Table 118: South America Pharmaceutical Drugs Market, 2016, By Segment

Table 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016

Table 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020

Table 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment

Table 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016

Table 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020

Table 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment

Table 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016

Table 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020

Table 129: Africa Pharmaceutical Drugs Market, 2016, By Segment

Table 130: Johnson & Johnson Financial Performance

Table 131: Novartis Ag Financial Performance

Table 132: F. Hoffmann-La Roche Ltd Financial Performance

Table 133: Pfizer Inc. Financial Performance

Table 134: Sanofi Financial Performance

Table 135: Pharmaceuticals Market Historic Growth

Table 136: Pharmaceuticals Market Forecast Growth

Table 137: Global Pharmaceuticals Market, 2016, By Region

Table 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region

Table 139: Pharmaceuticals Market, 2016, By Country

Table 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country

Table 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment

Table 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment

Table 143: Pharmaceuticals Market Size, Percentage Of GDP, Global

Table 144: Per Capita Average Pharmaceuticals Expenditure, Global

Table 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries

Table 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country

Table 147: Per Capita Average Pharmaceuticals Expenditure, By Country

Table 148: Healthcare Industry Financial Margins


List Of Table

Figure 1: Global Pharmaceutical Drugs Historic Market Growth

Figure 2: Global Pharmaceutical Drugs Forecast Market Growth

Figure 3: Pharmaceutical Drugs Market Segmentation

Figure 4: Global Pharmaceutical Drugs Market, 2016, By Segment

Figure 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016

Figure 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Figure 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region

Figure 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country

Figure 10: Global Cardiovascular Disorders Market, 2016, By Segment

Figure 11: Global Dermatology Market, 2016, By Segment

Figure 12: Global Gastrointestinal Diseases Market, 2016, By Segment

Figure 13: Global Genito-urinary Disorders Market, 2016, By Segment

Figure 14: Global Hematology Market, 2016, By Segment

Figure 15: Global Infectious Diseases Market, 2016, By Segment

Figure 16: Global Metabolic Disorders Market, 2016, By Segment

Figure 17: Global Musculoskeletal Disorders Market, 2016, By Segment

Figure 18: Global Central Nervous System Market, 2016, By Segment

Figure 19: Global Oncology Market, 2016, By Segment

Figure 20: Global Ophthalmology Market, 2016, By Segment

Figure 21: Global Respiratory Diseases Market, 2016, By Segment

Figure 22: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 24: Pharmaceutical Drugs Market, 2016, By Country

Figure 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 26: Global Healthcare Market Segments, 2016, By Region;

Figure 27: Global Pharmaceutical Market Segments, 2016, By Region;

Figure 28: Global Healthcare Market Segments, 2016, By Country;

Figure 29: Global Pharmaceutical Market Segments, 2016, By Country;

Figure 30: Global Pharmaceuticals Market Segments, 2016, By Region

Figure 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 32: Global Pharmaceuticals Market Segments, 2016, By Country

Figure 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 39: Global Number Of Pharmacists, 2016, By Country

Figure 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 41: Global Number Of Pharma Enterprises, 2016, By Country

Figure 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 43: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 47: Global Number Of General Practitioners 2016, By Country

Figure 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016

Figure 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment

Figure 52: China Pharmaceutical Drugs Historic Market, 2012-2016

Figure 53: China Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 54: China Pharmaceutical Drugs Market, 2016, By Segment

Figure 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 57: India Pharmaceutical Drugs Historic Market, 2012-2016

Figure 58: India Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 59: India Pharmaceutical Drugs Market, 2016, By Segment

Figure 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016

Figure 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 64: Japan Pharmaceutical Drugs Market, 2016, By Segment

Figure 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016

Figure 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 69: Australia Pharmaceutical Drugs Market, 2016, By Segment

Figure 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016

Figure 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment

Figure 75: UK Pharmaceutical Drugs Historic Market, 2012-2016

Figure 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 77: UK Pharmaceutical Drugs Market, 2016, By Segment

Figure 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016

Figure 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 82: Germany Pharmaceutical Drugs Market, 2016, By Segment

Figure 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 85: France Pharmaceutical Drugs Historic Market, 2012-2016

Figure 86: France Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 87: France Pharmaceutical Drugs Market, 2016, By Segment

Figure 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016

Figure 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 92: Italy Pharmaceutical Drugs Market, 2016, By Segment

Figure 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016

Figure 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 97: Spain Pharmaceutical Drugs Market, 2016, By Segment

Figure 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016

Figure 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment

Figure 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016

Figure 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 105: Russia Pharmaceutical Drugs Market, 2016, By Segment

Figure 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 108: North America Pharmaceutical Drugs Historic Market, 2012-2016

Figure 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 110: North America Pharmaceutical Drugs Market, 2016, By Segment

Figure 111: USA Pharmaceutical Drugs Historic Market, 2012-2016

Figure 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 113: USA Pharmaceutical Drugs Market, 2016, By Segment

Figure 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 116: South America Pharmaceutical Drugs Historic Market, 2012-2016

Figure 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 118: South America Pharmaceutical Drugs Market, 2016, By Segment

Figure 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016

Figure 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment

Figure 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016

Figure 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment

Figure 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016

Figure 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 129: Africa Pharmaceutical Drugs Market, 2016, By Segment

Figure 130: Johnson & Johnson Financial Performance

Figure 131: Novartis Ag Financial Performance

Figure 132: F. Hoffmann-La Roche Ltd Financial Performance

Figure 133: Pfizer Inc. Financial Performance

Figure 134: Sanofi Financial Performance

Figure 135: Pharmaceuticals Market Historic Growth

Figure 136: Pharmaceuticals Market Forecast Growth

Figure 137: Global Pharmaceuticals Market, 2016, By Region

Figure 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region

Figure 139: Pharmaceuticals Market, 2016, By Country

Figure 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country

Figure 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment

Figure 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment

Figure 143: Pharmaceuticals Market Size, Percentage Of GDP, Global

Figure 144: Per Capita Average Pharmaceuticals Expenditure, Global

Figure 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries

Figure 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country

Figure 147: Per Capita Average Pharmaceuticals Expenditure, By Country

Figure 148: Healthcare Industry Financial Margins

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Cardiovascular Drugs, Dermatological Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Drugs For Infectious Diseases, Drugs For Metabolic Disorders, Drugs For Musculoskeletal Disorders, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Drugs For Respiratory Diseases


Companies

Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi

Company Profile

Company Profile Title

The market segments in the pharmaceuticals drugs sector as of 2016 were Oncology, Anti-diabetics, Anti-rheumatics, Anti-virals, Vaccines, Bronchodilators, Sensory Organs, Anti-hypertensives, MS Therapies, Immunosuppressants, Anti-coagulants, Dermatologicals, Anti-hyperlipidaemics, Anti-fibrinolytics and Anti-bacterials.

Pharmaceuticals Drugs was the largest segment in the pharmaceuticals market with over 80% share of the market. Pharmaceuticals Drugs are chemical substances used to treat, cure, prevent or diagnose a disease. Biologics was the second largest segment in the pharmaceuticals market with around 20% share of the market. Biologics comprises products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins extracted or semi synthesized from biological sources.

The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.

Rise of Biologics/Gene Therapy was observed to be one of the top trends in the pharmaceuticals industry as of 2016. Advances in genetics, molecular biology and gene delivery technologies have led to an increase in gene therapies to treat a number of diseases. Gene therapy treatment includes the isolation and transfer of stem cell populations, administration of effector cells and induction of pluripotent cells. Applications of gene therapy and biologics are primarily in cancer, cardiovascular and central nervous system diseases. Gene therapy is being widely used by healthcare service providers as it has the potential to cure hereditary diseases such as cystic fibrosis and also has the scope to treat heart diseases and cancer. For instance, cancer gene therapy is expected to be around $4.3 billion, thus indicating high demand for gene therapy

The Pharmaceutical Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases

Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Scope

1. Pharmaceutical Drugs Market Characteristics;

2. Pharmaceutical Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Pharmaceutical Drugs Market Customer Information;

5. Pharmaceutical Drugs Market Segmentation;

5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;

6. Pharmaceutical Drugs Market Regional And Country Analysis;

6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;

7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;

7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;

8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;

9. Pharmaceutical Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Pharmaceutical Drugs Market;

10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

11. Western Europe Pharmaceutical Drugs Market;

11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

12. Eastern Europe Pharmaceutical Drugs Market;

12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

13. North America Pharmaceutical Drugs Market;

13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

14. South America Pharmaceutical Drugs Market;

14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;

15. Middle East Pharmaceutical Drugs Market;

15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;

16. Africa Pharmaceutical Drugs Market;

16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;

17. Pharmaceutical Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

19. Market Background: Pharmaceuticals Market;

19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;

20. Healthcare Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Pharmaceutical Drugs Historic Market Growth

Table 2: Global Pharmaceutical Drugs Forecast Market Growth

Table 3: Pharmaceutical Drugs Market Segmentation

Table 4: Global Pharmaceutical Drugs Market, 2016, By Segment

Table 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016

Table 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Table 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region

Table 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country

Table 10: Global Cardiovascular Disorders Market, 2016, By Segment

Table 11: Global Dermatology Market, 2016, By Segment

Table 12: Global Gastrointestinal Diseases Market, 2016, By Segment

Table 13: Global Genito-urinary Disorders Market, 2016, By Segment

Table 14: Global Hematology Market, 2016, By Segment

Table 15: Global Infectious Diseases Market, 2016, By Segment

Table 16: Global Metabolic Disorders Market, 2016, By Segment

Table 17: Global Musculoskeletal Disorders Market, 2016, By Segment

Table 18: Global Central Nervous System Market, 2016, By Segment

Table 19: Global Oncology Market, 2016, By Segment

Table 20: Global Ophthalmology Market, 2016, By Segment

Table 21: Global Respiratory Diseases Market, 2016, By Segment

Table 22: Global Pharmaceutical Drugs Market, 2016, By Region

Table 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 24: Pharmaceutical Drugs Market, 2016, By Country

Table 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 26: Global Healthcare Market Segments, 2016, By Region;

Table 27: Global Pharmaceutical Market Segments, 2016, By Region;

Table 28: Global Healthcare Market Segments, 2016, By Country;

Table 29: Global Pharmaceutical Market Segments, 2016, By Country;

Table 30: Global Pharmaceuticals Market Segments, 2016, By Region

Table 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 32: Global Pharmaceuticals Market Segments, 2016, By Country

Table 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 39: Global Number Of Pharmacists, 2016, By Country

Table 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 41: Global Number Of Pharma Enterprises, 2016, By Country

Table 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 43: Global Average Spending On R&D/Product Development, 2016, By Country

Table 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 47: Global Number Of General Practitioners 2016, By Country

Table 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016

Table 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020

Table 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment

Table 52: China Pharmaceutical Drugs Historic Market, 2012-2016

Table 53: China Pharmaceutical Drugs Forecast Market, 2016-2020

Table 54: China Pharmaceutical Drugs Market, 2016, By Segment

Table 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 57: India Pharmaceutical Drugs Historic Market, 2012-2016

Table 58: India Pharmaceutical Drugs Forecast Market, 2016-2020

Table 59: India Pharmaceutical Drugs Market, 2016, By Segment

Table 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016

Table 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020

Table 64: Japan Pharmaceutical Drugs Market, 2016, By Segment

Table 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016

Table 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020

Table 69: Australia Pharmaceutical Drugs Market, 2016, By Segment

Table 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016

Table 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Table 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment

Table 75: UK Pharmaceutical Drugs Historic Market, 2012-2016

Table 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020

Table 77: UK Pharmaceutical Drugs Market, 2016, By Segment

Table 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016

Table 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020

Table 82: Germany Pharmaceutical Drugs Market, 2016, By Segment

Table 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 85: France Pharmaceutical Drugs Historic Market, 2012-2016

Table 86: France Pharmaceutical Drugs Forecast Market, 2016-2020

Table 87: France Pharmaceutical Drugs Market, 2016, By Segment

Table 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016

Table 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020

Table 92: Italy Pharmaceutical Drugs Market, 2016, By Segment

Table 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016

Table 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020

Table 97: Spain Pharmaceutical Drugs Market, 2016, By Segment

Table 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016

Table 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Table 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment

Table 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016

Table 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020

Table 105: Russia Pharmaceutical Drugs Market, 2016, By Segment

Table 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 108: North America Pharmaceutical Drugs Historic Market, 2012-2016

Table 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020

Table 110: North America Pharmaceutical Drugs Market, 2016, By Segment

Table 111: USA Pharmaceutical Drugs Historic Market, 2012-2016

Table 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020

Table 113: USA Pharmaceutical Drugs Market, 2016, By Segment

Table 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 116: South America Pharmaceutical Drugs Historic Market, 2012-2016

Table 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020

Table 118: South America Pharmaceutical Drugs Market, 2016, By Segment

Table 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016

Table 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020

Table 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment

Table 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Table 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Table 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016

Table 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020

Table 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment

Table 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016

Table 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020

Table 129: Africa Pharmaceutical Drugs Market, 2016, By Segment

Table 130: Johnson & Johnson Financial Performance

Table 131: Novartis Ag Financial Performance

Table 132: F. Hoffmann-La Roche Ltd Financial Performance

Table 133: Pfizer Inc. Financial Performance

Table 134: Sanofi Financial Performance

Table 135: Pharmaceuticals Market Historic Growth

Table 136: Pharmaceuticals Market Forecast Growth

Table 137: Global Pharmaceuticals Market, 2016, By Region

Table 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region

Table 139: Pharmaceuticals Market, 2016, By Country

Table 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country

Table 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment

Table 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment

Table 143: Pharmaceuticals Market Size, Percentage Of GDP, Global

Table 144: Per Capita Average Pharmaceuticals Expenditure, Global

Table 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries

Table 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country

Table 147: Per Capita Average Pharmaceuticals Expenditure, By Country

Table 148: Healthcare Industry Financial Margins


List Of Table

Figure 1: Global Pharmaceutical Drugs Historic Market Growth

Figure 2: Global Pharmaceutical Drugs Forecast Market Growth

Figure 3: Pharmaceutical Drugs Market Segmentation

Figure 4: Global Pharmaceutical Drugs Market, 2016, By Segment

Figure 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016

Figure 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Figure 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region

Figure 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country

Figure 10: Global Cardiovascular Disorders Market, 2016, By Segment

Figure 11: Global Dermatology Market, 2016, By Segment

Figure 12: Global Gastrointestinal Diseases Market, 2016, By Segment

Figure 13: Global Genito-urinary Disorders Market, 2016, By Segment

Figure 14: Global Hematology Market, 2016, By Segment

Figure 15: Global Infectious Diseases Market, 2016, By Segment

Figure 16: Global Metabolic Disorders Market, 2016, By Segment

Figure 17: Global Musculoskeletal Disorders Market, 2016, By Segment

Figure 18: Global Central Nervous System Market, 2016, By Segment

Figure 19: Global Oncology Market, 2016, By Segment

Figure 20: Global Ophthalmology Market, 2016, By Segment

Figure 21: Global Respiratory Diseases Market, 2016, By Segment

Figure 22: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 24: Pharmaceutical Drugs Market, 2016, By Country

Figure 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 26: Global Healthcare Market Segments, 2016, By Region;

Figure 27: Global Pharmaceutical Market Segments, 2016, By Region;

Figure 28: Global Healthcare Market Segments, 2016, By Country;

Figure 29: Global Pharmaceutical Market Segments, 2016, By Country;

Figure 30: Global Pharmaceuticals Market Segments, 2016, By Region

Figure 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 32: Global Pharmaceuticals Market Segments, 2016, By Country

Figure 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 39: Global Number Of Pharmacists, 2016, By Country

Figure 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 41: Global Number Of Pharma Enterprises, 2016, By Country

Figure 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 43: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 47: Global Number Of General Practitioners 2016, By Country

Figure 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016

Figure 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment

Figure 52: China Pharmaceutical Drugs Historic Market, 2012-2016

Figure 53: China Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 54: China Pharmaceutical Drugs Market, 2016, By Segment

Figure 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 57: India Pharmaceutical Drugs Historic Market, 2012-2016

Figure 58: India Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 59: India Pharmaceutical Drugs Market, 2016, By Segment

Figure 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016

Figure 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 64: Japan Pharmaceutical Drugs Market, 2016, By Segment

Figure 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016

Figure 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 69: Australia Pharmaceutical Drugs Market, 2016, By Segment

Figure 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016

Figure 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment

Figure 75: UK Pharmaceutical Drugs Historic Market, 2012-2016

Figure 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 77: UK Pharmaceutical Drugs Market, 2016, By Segment

Figure 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016

Figure 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 82: Germany Pharmaceutical Drugs Market, 2016, By Segment

Figure 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 85: France Pharmaceutical Drugs Historic Market, 2012-2016

Figure 86: France Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 87: France Pharmaceutical Drugs Market, 2016, By Segment

Figure 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016

Figure 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 92: Italy Pharmaceutical Drugs Market, 2016, By Segment

Figure 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016

Figure 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 97: Spain Pharmaceutical Drugs Market, 2016, By Segment

Figure 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016

Figure 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment

Figure 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016

Figure 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 105: Russia Pharmaceutical Drugs Market, 2016, By Segment

Figure 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 108: North America Pharmaceutical Drugs Historic Market, 2012-2016

Figure 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 110: North America Pharmaceutical Drugs Market, 2016, By Segment

Figure 111: USA Pharmaceutical Drugs Historic Market, 2012-2016

Figure 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 113: USA Pharmaceutical Drugs Market, 2016, By Segment

Figure 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 116: South America Pharmaceutical Drugs Historic Market, 2012-2016

Figure 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 118: South America Pharmaceutical Drugs Market, 2016, By Segment

Figure 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016

Figure 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment

Figure 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020

Figure 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020

Figure 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016

Figure 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment

Figure 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016

Figure 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020

Figure 129: Africa Pharmaceutical Drugs Market, 2016, By Segment

Figure 130: Johnson & Johnson Financial Performance

Figure 131: Novartis Ag Financial Performance

Figure 132: F. Hoffmann-La Roche Ltd Financial Performance

Figure 133: Pfizer Inc. Financial Performance

Figure 134: Sanofi Financial Performance

Figure 135: Pharmaceuticals Market Historic Growth

Figure 136: Pharmaceuticals Market Forecast Growth

Figure 137: Global Pharmaceuticals Market, 2016, By Region

Figure 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region

Figure 139: Pharmaceuticals Market, 2016, By Country

Figure 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country

Figure 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment

Figure 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment

Figure 143: Pharmaceuticals Market Size, Percentage Of GDP, Global

Figure 144: Per Capita Average Pharmaceuticals Expenditure, Global

Figure 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries

Figure 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country

Figure 147: Per Capita Average Pharmaceuticals Expenditure, By Country

Figure 148: Healthcare Industry Financial Margins

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Cardiovascular Drugs, Dermatological Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Drugs For Infectious Diseases, Drugs For Metabolic Disorders, Drugs For Musculoskeletal Disorders, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Drugs For Respiratory Diseases


Companies

Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi